Ivonne Maciel Arciniega-Martínez

Dr. Ivonne Maciel Arciniega-Martínez

Instituto Politécnico Nacional, Mexico City, Ciudad de México, Mexico
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2008 in Microbial Pathogenesis
Verified
Journal Article
Closed access
JGJavier Gutiérrez-Jiménez
Javier Gutiérrez-Jiménez
IAIvonne Maciel Arciniega-Martínez
Ivonne Maciel Arciniega-Martínez
FNFernando Navarro-García
Fernando Navarro-García

7 July 2020 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
MHMaricarmen Hernández-Rodríguez
Maricarmen Hernández-Rodríguez
IAIvonne Maciel Arciniega-Martínez
Ivonne Maciel Arciniega-Martínez
IGIohanan Daniel García-Marín
Iohanan Daniel García-Marín
CJCORREA BASURTO JOSE
CORREA BASURTO JOSE
MRMartha Cecilia Rosales-hernendez
Martha Cecilia Rosales-hernendez

4 May 2019 in Expert Opinion on Therapeutic Patents
Verified
Journal Article
Closed access
KRKarla S. Romero-Aguilar
Karla S. Romero-Aguilar
IAIvonne Maciel Arciniega-Martínez
Ivonne Maciel Arciniega-Martínez
EFEunice D. Farfán-García
Eunice D. Farfán-García
RCRafael Campos-Rodríguez
Rafael Campos-Rodríguez
ARAldo Arturo Reséndiz-Albor
Aldo Arturo Reséndiz-Albor
Marvin A. Soriano-UrsuaMarvin A. Soriano-Ursua
Marvin A. Soriano-Ursua
Introduction: Boron-containing compounds induce effects on immune responses. Such effects are interesting to the biomedical field for the development of therapeutic tools to modulate the immune system. Areas covered: The scope of BCC use to modify immune responses is expanding, mainly with regard to inflammatory diseases. The information was organized to demonstrate the breadth of reported effects. BCCs act as modulators of innate and adaptive immunity, with the former including regulation of cluster differentiation and cytokine production. In addition, BCCs exert effects on inflammation induced by infectious and noninfectious agents, and there are also reports regarding their effects on mechanisms involving hypersensitivity and transplants. Finally, the authors discuss the beneficial effects of BCCs on pathologies involving various targets and mechanisms. Expert opinion: Some BCCs are currently used as drugs in humans. The mechanisms by which these BCCs modulate immune responses, as well as the required structure–activity relationship for each observed mechanism of action, should be clarified. The former will allow for the development of improved immunomodulatory drugs with extensive applications in medicine. Patenting trends involve claims concerning the synthesis and actions of identified molecules with a defined profile regarding cytokines, cell differentiation, proliferation, and antibody production.

1 February 2009 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
JGJames E. Galen
James E. Galen
MCMagaly Chinchilla
Magaly Chinchilla
MPMarcela F. Pasetti
Marcela F. Pasetti
JWJin Yuan Wang
Jin Yuan Wang
LZLicheng Zhao
Licheng Zhao
MLMyron M Max Levine
Myron M Max Levine
Salmonella entericag serovar Typhi vaccine strain CVD 908-htrA was genetically engineered for stable plasmidbased expression of protective antigen of

30 August 2015 in Archivum Immunologiae et Therapiae Experimentalis
Verified
Journal Article
Closed access
PDF file
IAIvonne Maciel Arciniega-Martínez
Ivonne Maciel Arciniega-Martínez
RCRafael Campos-Rodríguez
Rafael Campos-Rodríguez
MDMaría Elisa Drago-Serrano
María Elisa Drago-Serrano
LUVIA ENID SANCHEZ-TORRESLUVIA ENID SANCHEZ-TORRES
LUVIA ENID SANCHEZ-TORRES
TCTeresita Rocío Cruz-Hernández
Teresita Rocío Cruz-Hernández
ARAldo Arturo Reséndiz-Albor
Aldo Arturo Reséndiz-Albor
Bovine lactoferrin (bLf) up-modulates intestinal IgA that is essential for homeostasis and which might confer protection to the distal small intestine that is vulnerable to inflammation. This study analyzed the effects of bLf administered orally on the IgA response at inductive (Peyer’s patches) and effector (lamina propria) sites of the distal small intestine in mice. Groups of five healthy male BALB/c mice were orally treated with 5 mg of bLf for 7, 14, 21, or 28 days. Then, mice were killed and the distal small intestine was dissected. Intestinal fluid samples were analyzed to determine IgA and IgM levels by enzyme-immuno assay. Peyer’s patches and lamina propria were analyzed for IgA+ or IgM+ plasma cells, B, CD4+ T and CD8+ T cells as well as CD4+ T cells positive for either pro-inflammatory cytokines [tumor necrosis factor (TNF)-α, interferon-γ and interleukin (IL)-12] or for IgA-producing ILs (IL-4, -5, -10 and -6) by cytofluorometry. Antibodies, antibody-secreting cells, and B and T responses in both Peyer’s patches and lamina propria were higher in bLf-treated than bLf-untreated mice. The generation of IL-10 and IL-6 CD4+ T cells in Peyer’s patches or TNF-α and IL-12 CD4+ T cells in lamina propria showed similar response patterns. On days 14 and 28, cytokine/IL CD4+ T cell responses were increased in Peyer’s patches or decreased in lamina propria. The effect of bLf on the elicitation of IgA indicates a potential application of bLf as a nutraceutical to control inflammation in the distal small intestine.

1 April 2018 in Journal of Lipids
Verified
Journal Article
Open access
PDF file
LGL. E. Gutiérrez-Pliego
L. E. Gutiérrez-Pliego
Beatriz Elina Martinez-CarrilloBeatriz Elina Martinez-Carrillo
Beatriz Elina Martinez-Carrillo
ARAldo Arturo Reséndiz-Albor
Aldo Arturo Reséndiz-Albor
IAIvonne Maciel Arciniega-Martínez
Ivonne Maciel Arciniega-Martínez
JEJ. A. Escoto-Herrera
J. A. Escoto-Herrera
BMBeatriz Elina Martínez-Carrillo
Beatriz Elina Martínez-Carrillo
Background. Diabetes mellitus is considered a chronic noncommunicable disease in which inflammation plays a main role in the progression of the disease and it is known thatn-3 fatty acids have anti-inflammatory properties. One of the most recent approaches is the study of the fatty acids of microalgae as a substitute for fish oil and a source rich in fatty acids EPA and DHA.Objective.To analyze the effect of supplementation withn-3 fatty acids extracted from microalgae on the inflammatory markers from two different strains of mice.Methods. Mice of two strains, db/db and CD1, were supplemented withn-3 fatty acids extracted from microalgae in lyophilized form and added to food; the experiment was carried out from week 8 to 16 of life. Flow cytometry was performed to determine the percentage of TCD4+ cells producing Th1 and Th2 cytokines.Results.Supplementation with microalgae fatty acids decreased the percentage of TCD4+ cells producing IFN-γand TNF-αand increased the ones producing IL-17A and IL-12 in both strains; on the other hand, supplementation decreased percentage of TCD4+ cells producing IL-4 and increased the ones producing TGF-β.Conclusions. Microalgaen-3 fatty acids could be a useful tool in the treatment of diabetes as well as in the prevention of the appearance of health complications caused by inflammatory states.